TriSalus Life Sciences (TLSI) Debt to Equity (2022 - 2026)
TriSalus Life Sciences posted quarterly Debt to Equity of $2.58 for Q1 2026, up 380.05% year-on-year from $0.54 in Q1 2025, and up 364.66% on a QoQ basis from -$0.98 in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of Debt to Equity data on file, last reported at $2.58 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 380.05% year-over-year to $2.58; the trailing twelve-month figure through Mar 2026 stood at $2.58 (up 380.05% YoY), and the FY2025 full-year result was -$0.98, down 14.43% from the prior year.
- Debt to Equity for Q1 2026 stood at $2.58, up from -$0.98 in the prior quarter.
- Across five years, Debt to Equity topped out at $2.58 in Q1 2026 and bottomed at -$1.66 in Q2 2025.
- The 5-year median for Debt to Equity is -$0.85 (2024), against an average of -$0.46.
- The widest annual swing landed in 2024, when Debt to Equity slumped 1564.01%; it then jumped 380.05% in 2026.
- A 5-year view of Debt to Equity shows it stood at -$0.01 in 2022, then sank by 265.79% to -$0.05 in 2023, then plunged by 1584.32% to -$0.85 in 2024, then slipped by 14.43% to -$0.98 in 2025, then surged by 364.66% to $2.58 in 2026.
- The last three Debt to Equity figures came in at $2.58 (Q1 2026), -$0.98 (Q4 2025), and -$1.23 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | 2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.58 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -1.23 |
| Jun 30, 2025 | -1.66 |
| Mar 31, 2025 | -0.92 |
| Dec 31, 2024 | -0.85 |
| Sep 30, 2024 | -1.06 |
| Jun 30, 2024 | -0.84 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.01 |